To reconcile this discrepancy between the Apcmin/+ mouse model and human colon cancer patients, it is necessary to examine whether CRHR1- or CRHR2-mediated responses would result in a similar effect in a different mouse model of colon cancer. The gene discussed is CRHR2; the disease is malignant colon neoplasm.